Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales

INTRODUCTION: A phase 3 randomized controlled study comparing triamcinolone acetonide extended-release (TA-ER) to conventional TA crystalline suspension (TAcs) reported variable efficacy results. Enrollment criteria may have contributed to this discrepancy, as moderate-to-severe average daily pain (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Edgar, Katz, Nathaniel P., Conaghan, Philip G., Kivitz, Alan, Turk, Dennis C., Spitzer, Andrew I., Jones, Deryk G., Lanier, Ryan K., Cinar, Amy, Lufkin, Joelle, Kelley, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861226/
https://www.ncbi.nlm.nih.gov/pubmed/34791634
http://dx.doi.org/10.1007/s40122-021-00335-z

Ejemplares similares

Ejemplares similares